Zacks Investment Research Downgrades Smiths Group (SMGZY) to Hold

Smiths Group (OTCMKTS:SMGZY) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued on Wednesday.

According to Zacks, “Smiths Group plc is a technology company. The Company designs, manufactures and delivers products and services for the threat & contraband detection, medical devices, energy and communications market. Its operating segment consists John Crane sector provides mechanical seals, seal support systems, engineered bearings, power transmission couplings and specialist filtration systems, Smiths Medical sector provides infusion systems, vascular access, patient airway and temperature management equipment and specialty devices. Smiths Detection sector provides sensors that detect and identify explosives, narcotics, weapons, chemical agents, biohazards and contraband; Smiths Interconnect sector provides specialised electronic and radio frequency components and sub-systems that connect, protect and control critical systems; Flex-Tek division provides engineered components that heat and move fluids and gases, flexible hosing and rigid tubing. Smiths Group plc is headquartered in London, the United Kingdom. “

Other analysts also recently issued research reports about the company. Numis Securities downgraded Smiths Group from an “add” rating to a “reduce” rating in a research report on Friday, March 23rd. Barclays assumed coverage on Smiths Group in a research report on Tuesday, February 13th. They issued an “overweight” rating for the company.

Shares of SMGZY stock opened at $23.13 on Wednesday. The company has a quick ratio of 1.83, a current ratio of 2.46 and a debt-to-equity ratio of 0.78. Smiths Group has a fifty-two week low of $19.14 and a fifty-two week high of $23.87. The company has a market capitalization of $9.00 billion, a price-to-earnings ratio of 18.80, a P/E/G ratio of 2.35 and a beta of 1.18.

Smiths Group Company Profile

Smiths Group plc designs, manufactures, and sells various products and services for the threat and contraband detection, medical devices, energy, communications, and engineered components markets worldwide. It operates through John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek divisions.

Get a free copy of the Zacks research report on Smiths Group (SMGZY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with's FREE daily email newsletter.

Leave a Reply